15809368

Source:http://linkedlifedata.com/resource/pubmed/id/15809368

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003402, umls-concept:C0023779, umls-concept:C0030705, umls-concept:C0042890, umls-concept:C0087111, umls-concept:C0151744, umls-concept:C0205081, umls-concept:C0205360, umls-concept:C1280500, umls-concept:C1527178, umls-concept:C1707455, umls-concept:C1801960, umls-concept:C1956346, umls-concept:C2003888, umls-concept:C2603343
pubmed:issue	14
pubmed:dateCreated	2005-4-12
pubmed:abstractText	Lipid lowering with statins prevents adverse cardiac events. Both lipid-lowering and antioxidant therapies may favorably affect vasomotor function and thereby improve ischemia.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/R01-HL38780
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15809368-16380043
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0147763
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants, http://linkedlifedata.com/resource/pubmed/chemical/Ascorbic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Lipids, http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, LDL, http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles, http://linkedlifedata.com/resource/pubmed/chemical/Vitamin E, http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1524-4539
pubmed:author	pubmed-author:AndrewsThomas CTC, pubmed-author:CarlsonWilliamW, pubmed-author:ColeHollyH, pubmed-author:CreagerMark AMA, pubmed-author:FreiBalzB, pubmed-author:JohnstoneMichaelM, pubmed-author:KinlayScottS, pubmed-author:Lloyd-JonesDonald MDM, pubmed-author:OravJohnJ, pubmed-author:RubensteinJoelJ, pubmed-author:SelwynAndrew PAP, pubmed-author:SopkoGeorgeG, pubmed-author:StonePeter HPH, pubmed-author:Vascular Basis Study Group
pubmed:issnType	Electronic
pubmed:day	12
pubmed:volume	111
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1747-55
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15809368-Angina Pectoris, pubmed-meshheading:15809368-Antioxidants, pubmed-meshheading:15809368-Ascorbic Acid, pubmed-meshheading:15809368-Coronary Artery Disease, pubmed-meshheading:15809368-Diet Therapy, pubmed-meshheading:15809368-Dose-Response Relationship, Drug, pubmed-meshheading:15809368-Exercise Test, pubmed-meshheading:15809368-Female, pubmed-meshheading:15809368-Heptanoic Acids, pubmed-meshheading:15809368-Humans, pubmed-meshheading:15809368-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:15809368-Lipid Metabolism, pubmed-meshheading:15809368-Lipids, pubmed-meshheading:15809368-Lipoproteins, LDL, pubmed-meshheading:15809368-Male, pubmed-meshheading:15809368-Myocardial Ischemia, pubmed-meshheading:15809368-Pyrroles, pubmed-meshheading:15809368-Vasomotor System, pubmed-meshheading:15809368-Vitamin E
pubmed:year	2005
pubmed:articleTitle	Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study.
pubmed:affiliation	Cardiovascular Division, Brigham & Women's Hospital, Boston, Mass 02115, USA. pstone@partners.org
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Research Support, N.I.H., Extramural